Roche Diagnostics International Ltd
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$46.3M
Doctors Paid
12,671
Transactions
31,137
2024 Total
$1.5M
Payment Breakdown by Category
Research$36.8M (79.4%)
Consulting$3.8M (8.2%)
Travel$915,826 (2.0%)
Food & Beverage$811,573 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $36.8M | 502 | 79.4% |
| Consulting Fee | $3.8M | 901 | 8.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 506 | 3.3% |
| Gift | $1.2M | 16 | 2.7% |
| Travel and Lodging | $915,826 | 1,453 | 2.0% |
| Education | $892,200 | 435 | 1.9% |
| Food and Beverage | $811,573 | 27,245 | 1.8% |
| Grant | $149,518 | 17 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $143,905 | 54 | 0.3% |
| Charitable Contribution | $63,401 | 1 | 0.1% |
| Long term medical supply or device loan | $12,802 | 5 | 0.0% |
| Debt forgiveness | $9,358 | 2 | 0.0% |
Payments by Type
Research
$36.8M
502 transactions
General
$9.5M
30,635 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| RD003208 | $5.7M | 0 | 16 |
| RD003724 | $2.5M | 0 | 2 |
| RD003017 | $2.1M | 0 | 8 |
| RD003299 | $1.8M | 0 | 4 |
| RD004081 | $1.4M | 0 | 1 |
| RD004723 | $1.1M | 0 | 5 |
| RD005021 | $898,760 | 0 | 3 |
| RD002687 | $873,128 | 0 | 1 |
| RD002991 | $815,416 | 0 | 3 |
| RD002605 | $808,786 | 0 | 4 |
| CSF AD Markers in Health and Disease | $782,834 | 0 | 3 |
| RD005216 | $761,465 | 0 | 7 |
| RD004743 | $686,278 | 0 | 1 |
| RD005277 | $679,847 | 0 | 3 |
| RD005394 | $626,864 | 0 | 11 |
| RD003707 | $614,584 | 0 | 4 |
| RD005671 | $544,967 | 0 | 4 |
| RD003657 | $455,936 | 0 | 2 |
| The IMpact of the Roche Elecsys sFlt-1/PlGF ratio on clinical decision making in suspected PreEclampsia (TIME PE) | $420,209 | 0 | 34 |
| RD005686 | $407,264 | 0 | 3 |
| Longitudinal Early-onset AD Study (LEADS) | $394,766 | 0 | 4 |
| RD005196 | $371,113 | 0 | 3 |
| RD001902 | $358,048 | 0 | 2 |
| RD002603 | $342,049 | 0 | 11 |
| RD003395 | $305,802 | 0 | 3 |
| RD006555 | $304,952 | 0 | 4 |
| RD002595: Pilot and Feasibility Heart Failure Prevention Study (2 of 3 Study) | $302,134 | 0 | 2 |
| RD005665 | $297,919 | 0 | 2 |
| RD003770 | $280,792 | 0 | 3 |
| RD003618 | $254,420 | 0 | 26 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Shannon Huff, Md, MD | Obstetrics & Gynecology | Lumberton, NC | $9,991 | $0 |
| James Leaming, M.d, M.D | Emergency Medicine | Camp Hill, PA | $9,916 | $0 |
| Dr. Jeffrey Gregg, M.d, M.D | Specialist | Sacramento, CA | $9,888 | $0 |
| Amy Fox, Md, MD | Pediatric Nephrology | Bronx, NY | $9,766 | $0 |
| Laura Newby, Md, MD | Cardiovascular Disease | Durham, NC | $9,756 | $0 |
| Cesar Moran, M.d, M.D | Anatomic Pathology | Houston, TX | $9,732 | $0 |
| Dr. Judd Hollander, Md, MD | Emergency Medicine | Philadelphia, PA | $9,674 | $0 |
| Unknown Provider | — | — | $9,631 | $0 |
| Dr. Mohamed Salama, Md, MD | Hematology | Austin, TX | $9,629 | $0 |
| Thaer Khoury, Md, MD | Anatomic Pathology & Clinical Pathology | Buffalo, NY | $9,620 | $0 |
| Lance Peterson, M.d, M.D | Clinical Pathology/Laboratory Medicine | Evanston, IL | $9,586 | $0 |
| Dr. Karin Molander, M.d, M.D | Emergency Medicine | Burlingame, CA | $9,579 | $0 |
| Zoran Gatalica, M.d, M.D | Anatomic Pathology & Clinical Pathology | Phoenix, AZ | $9,540 | $0 |
| Megan App, M.d, M.D | Obstetrics & Gynecology | Portage, IN | $9,526 | $0 |
| Brandon Allen, Md, MD | Student in an Organized Health Care Education/Training Program | Gainesville, FL | $9,494 | $0 |
| Vishnu Parthasarathy | Student in an Organized Health Care Education/Training Program | San Diego, CA | $9,433 | $0 |
| Dr. Robert Mentz, Md, MD | Internal Medicine | Durham, NC | $9,393 | $0 |
| Dr. Subbian Karumanchi, M.d, M.D | Nephrology | Boston, MA | $9,192 | $0 |
| Angela Caliendo, M.d., Ph.d, M.D., PH.D | Infectious Disease | Providence, RI | $9,031 | $0 |
| Eric Konnick, Md, MD | Anatomic Pathology & Clinical Pathology | Seattle, WA | $8,821 | $0 |
| Dr. Kamaljit Singh, M.d, M.D | Medical Microbiology | Chicago, IL | $8,786 | $0 |
| Dr. Raul Benavides, M.d, M.D | Clinical Pathology/Laboratory Medicine | Dallas, TX | $8,731 | $0 |
| Dr. Michael Laposata, Md, Phd, MD, PHD | Clinical Pathology/Laboratory Medicine | Galveston, TX | $8,654 | $0 |
| Dr. Samuel Wolf, D.o, D.O | Obstetrics & Gynecology | Panama City, FL | $8,636 | $0 |
| Dr. Teresa Darragh, Md, MD | Cytopathology | San Francisco, CA | $8,397 | $0 |
Ad
Top Products
- CD cobas Reagents $23.8M
- cobas c 311 $2.9M
Associated Products (41)
- CD cobas Reagents $39.9M
- cobas c 311 $5.9M
- cobas 6000 Core Unit $2.9M
- CD cobas Analyzer Series $1.5M
- TD BenchMark IHC/ISH and Special Stains Reagents $1.1M
- MD cobas Instruments and Reagents $835,256
- DIS Navify Software $794,873
- POC CoaguChek Meters, Strips and Accessories $544,527
- cobas 8000 Core Unit $535,750
- NAVIFY Products $510,257
- RS Harmony Test Related Products $407,958
- POC cobas Liat Analyzer, Assays, Controls and Accessories $405,079
- CD cobas Automation $359,672
- CINtec PLUS Cytology $194,663
- RDI Research $191,845
- RS Sequencing Reagents and Assays $151,366
- BENCHMARK SPECIAL STAINS WASH II $130,766
- cobas Liat Analyzer $115,706
- MD Cobas 6800 8800 $103,977
- CD Middleware Solutions $103,678
- TD BenchMark Platforms $102,270
- TD VENTANA Primary Staining Instruments and Reagents $99,006
- CoaguChek Meters, Strips and Accessories $98,178
- cobas HBV/HCV/HIV-1 Control Kit $74,163
- BCM for cobas 8100 $71,091
- RS Sequencing Instruments $69,584
- MD Research and Development $64,667
- POC ACCU-CHEK Inform II Meters, Strips and Assessories $62,778
- MD Cobas Instruments and Reagents $45,429
- VIRTUOSO System for IHC $40,891
- POC ACCU-CHEK Safe-T-Pro Lancets $39,059
- cobas pro ISE analytical unit $35,986
- KIT COBAS 6800/8800 SARS-COV-2/FLU 384T $32,063
- TD VENTANA Digital Pathology Products $26,608
- RS Genomic Analysis Software $24,153
- RS Research and Development $21,129
- PD CD Lab Operations $18,197
- cobas c 503 analytical unit $13,800
- cobas 4800 CTNG Test v20 $13,507
- BenchMark Special Stains Wash II $10,456
- AS Sequencing $10,259
Payment Categories
- Food & Beverage $811,573
- Consulting $3.8M
- Travel & Lodging $915,826
- Research $36.8M
About Roche Diagnostics International Ltd
Roche Diagnostics International Ltd has made $46.3M in payments to 12,671 healthcare providers, recorded across 31,137 transactions in the CMS Open Payments database. In 2024, the company paid $1.5M. The top product by payment volume is CD cobas Reagents ($23.8M).
Payments were distributed across 156 medical specialties. The top specialty by payment amount is Anatomic Pathology & Clinical Pathology ($883,465 to 1,295 doctors).
Payment categories include: Food & Beverage ($811,573), Consulting ($3.8M), Research ($36.8M), Travel & Lodging ($915,826).
Roche Diagnostics International Ltd is associated with 41 products in the CMS Open Payments database, including CD cobas Reagents, cobas c 311, and cobas 6000 Core Unit.